Records containing: Thyroid Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-09Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2025-10-08Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma
-
CLINICAL_TRIALS study record update · 2025-10-07Phase II Study of PDR001 in Combination With MAPK Pathway Inhibitors in Patients With Radioiodine-Refractory Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-10-06Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism - a Randomized, Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-10-02Prospective, Observational Study on the Investigation of the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-01The Role of Environmental Factors in Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-09-23Study of the Predictive Value of a Signature of microRNA in Thyroid Cytologies of Undetermined Type
-
CLINICAL_TRIALS study record update · 2025-09-22A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
-
CLINICAL_TRIALS study record update · 2025-09-19Post-thyroid Surgery Adhesion Prevention Using Oxidized Regenerated Cellulose and Hyaluronic Acid: Prospective, Single-blinded, Randomized Study
-
CLINICAL_TRIALS study record update · 2025-09-18Interest of the Virtual Reality Headset in the Management of Perioperative Stress in Patients Candidates for Total Thyroidectomy
-
CLINICAL_TRIALS study record update · 2025-09-15High Frame Rate 3-D Super Resolution Ultrasound Microvascular Imaging
-
CLINICAL_TRIALS study record update · 2025-09-10Patient-centered Decision Support Tool for Levothyroxine Dosage
-
CLINICAL_TRIALS study record update · 2025-09-02More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated
-
CLINICAL_TRIALS study record update · 2025-08-26Enhanced Assistance During Radiotherapy for Unmet Essential Needs (EARN): a Single Center Hybrid Type 1 Efficacy-implementation Study
-
CLINICAL_TRIALS study record update · 2025-08-15A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNS-101 (Anti VISTA) as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-08-15Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
-
CLINICAL_TRIALS study record update · 2025-08-03Retrospective and Prospective Evaluation of the Impact of Innovative and Conventional Treatments and of Clinical Variables on the Outcome of Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-08-03Measuring Patient Expectations for Thyroid Surgery: Development of a Patient-Reported Outcomes Instrument
-
CLINICAL_TRIALS study record update · 2025-07-31Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
-
CLINICAL_TRIALS study record update · 2025-07-25Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) - A Phase 2 Multi-centre Trial
-
CLINICAL_TRIALS study record update · 2025-07-24A Phase II Study to Explore the Safety and Efficacy of Multiple Target Kinase Inhibitor(mTKI) Combined With Anti-Programmed Death-1(PD-1) Antibody in the Treatment of Advanced Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-07-22Phase II Study Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-07-17Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy: A Prospective Study.
-
CLINICAL_TRIALS study record update · 2025-07-09Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
-
CLINICAL_TRIALS study record update · 2025-07-02A Pilot Study of the Addition of Cemiplimab, an Antibody to PD-1, to the Treatment of Subjects With BRAF-Mutant Anaplastic Thyroid Cancer Who Are No Longer Responding to Dabrafenib and Trametinib